Research focus

RC-SML operates across four main research domains:

1. Clinical research The clinical goal is to develop technologies for personalized medicine, including stem cell-based therapies, active and tissue-engineered implants, and medical devices.
2. Organ-on-chip modelling This area focuses on the development of next-generation in vitro models that replicate human organ systems by integrating advanced technologies with stem cell-derived human cells.
3. Biological research The biological focus is to understand stem cell fate and function from genetic, biochemical, and biophysical perspectives, as well as cell–biomaterial interactions in complex environments.
4. Engineering research Engineering efforts target the development of materials, nicrodevices, methods, and computational models to address biological and clinical challenges.

Organisation

To ensure efficient operation, RC-SML is structured into three thematic areas:

1. In vitro and in vivo tissue engineering
2. Biomedical microsystems and biomeasurements
3. Clinical translation

The leaders of these thematic areas, together with the RC leadership, form the RC board.

Education and Training

High-quality research and education are closely integrated within RC-SML.

• The Centre currently hosts over 80 PhD students and has supervised more than 100 doctoral theses over the past decade.
• The doctoral candidates are part of the Faculty’s Doctoral Programme in Medicine, Biosciences and Biomedical Engineering.
• Annually, approximately 40 MSc and BSc theses are supervised, primarily within the Centre’s degree programmes, but also in collaboration with other national and international universities (e.g., via Erasmus).

All PIs and several researchers contribute actively to teaching, including responsibility for courses and degree programme majors and minors.

Degree programme details can be found on the MET Faculty website.